Clinical Trial Update: A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of Topamax (topiramate) for treating obesity in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Obesity

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Hypertension | Phase 3 | Status: COMPLETED